34 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
7 Sep 23
Report of Foreign Private Issuer
7:25am
Selective A3AR Agonist Molecular weight - 510.29 Water insoluble Half lifetime in blood – 8 - 9 hours Piclidenoson Drug Candidate Chemical Properties … : 544.73 g/mol Water Insoluble Half life: 12 hours Nucleoside Derivative Orally Bioavailable High Stability in the Liver Namodenoson Drug Candidate
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
25 Jul 22
Report of Foreign Private Issuer
4:30pm
focuses on three areas of operation - Cleantech / Water, Financial Services, Retail/Trading. Mr. Regev is currently also the Chief Executive Officer
6-K
EX-99.1
8scrg2addh3f rer
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
e216v4ozqp
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
hgoz5y ipo2kqp
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
3lmlx 3o9
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
aag6sderewiifyn nj
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
7z5wbd s5
6 Nov 19
2019 Annual General Meeting of Shareholders
4:42pm
20-F/A
ma4am
2 Apr 19
Annual report (foreign) (amended)
6:52am
424B3
q7yd2p
22 Mar 19
Prospectus supplement
4:50pm
F-1/A
919lf
12 Mar 19
Registration statement (foreign) (amended)
4:20pm
F-1
0kh6 lq5r5yny30nd1f
15 Feb 19
Registration statement (foreign)
4:32pm
6-K
EX-99.1
ccl9gakuazpb6r
25 Oct 18
2018 Annual General Meeting of Shareholders
4:05pm